Controlled trial of nimodipine in subarachnoid hemorrhage

Completed

Phase N/A Results

Summary of Purpose

To determine whether treatment with nimodipine would prevent or reduce the severity of ischemic neurologic deficits from arterial spasm.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Miles Pharmaceuticals.

Trial Design

Prospective, double-blind, randomized, stratified, placebo-controlled trial of 125 patients at 5 centers. Patients stratified by center and treating physician.

Contacts

Not available